BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 23857971)

  • 21. [Expressions of CXCL13, CD10 and bcl-6 in angioimmunoblastic T-cell lymphoma and peripheral T-cell lymphoma, not otherwise specified].
    Tang XF; Li GD; Li YL; Liang DN; Xia T; Zhou JY; Yao YQ; Wu WQ; Wang ZG; Yang YH; Tang XB; Bai YQ; Ding Q
    Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):224-30. PubMed ID: 19575892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bortezomib in combination with CHOP as first-line treatment for patients with stage III/IV peripheral T-cell lymphomas: a multicentre, single-arm, phase 2 trial.
    Kim SJ; Yoon DH; Kang HJ; Kim JS; Park SK; Kim HJ; Lee J; Ryoo BY; Ko YH; Huh J; Yang WI; Kim HK; Min SK; Lee SS; Do IG; Suh C; Kim WS;
    Eur J Cancer; 2012 Nov; 48(17):3223-31. PubMed ID: 22770877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular classification of T-cell lymphomas.
    de Leval L; Bisig B; Thielen C; Boniver J; Gaulard P
    Crit Rev Oncol Hematol; 2009 Nov; 72(2):125-43. PubMed ID: 19233683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological and Molecular Features of Nodal Peripheral T-Cell Lymphomas.
    Satou A; Takahara T; Tsuzuki T
    Diagnostics (Basel); 2022 Aug; 12(8):. PubMed ID: 36010351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular understanding of peripheral T-cell lymphomas, not otherwise specified (PTCL, NOS): A complex disease category.
    Sakata-Yanagimoto M; Fukumoto K; Karube K; Chiba S
    J Clin Exp Hematop; 2021 Jun; 61(2):61-70. PubMed ID: 33716242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CHOEP-21 chemotherapy for newly diagnosed nodal peripheral T-cell lymphomas (PTCLs) in Maharaj Nakorn Chiang Mai Hospital.
    Rattarittamrong E; Norasetthada L; Tantiworawit A; Chai-Adisaksopha C; Nawarawong W
    J Med Assoc Thai; 2013 Nov; 96(11):1416-22. PubMed ID: 24428090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical and prognostic differences between ALK-negative anaplastic large cell lymphoma and peripheral T cell lymphoma, not otherwise specified: a single institution experience.
    Deng XW; Zhang XM; Wang WH; Wang SL; Jin J; Fang H; Ren H; Liu YP; He XH; Dong M; Song YW; Li YX
    Ann Hematol; 2016 Aug; 95(8):1271-80. PubMed ID: 27209536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations.
    Zettl A; Rüdiger T; Konrad MA; Chott A; Simonitsch-Klupp I; Sonnen R; Müller-Hermelink HK; Ott G
    Am J Pathol; 2004 May; 164(5):1837-48. PubMed ID: 15111330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of Peripheral T-cell Lymphoma Diagnostic Workup in the United States.
    Hsi ED; Horwitz SM; Carson KR; Pinter-Brown LC; Rosen ST; Pro B; Federico M; Gisselbrecht C; Schwartz M; Bellm LA; Acosta M; Collie AM; Gruver AM; Grzywacz BJ; Turakhia S; Shustov AR; Advani RH; Feldman T; Lechowicz MJ; Smith SM; Lansigan F; Tulpule A; Craig MD; Greer JP; Kahl BS; Leach JW; Morganstein N; Casulo C; Park SI; Foss FM
    Clin Lymphoma Myeloma Leuk; 2017 Apr; 17(4):193-200. PubMed ID: 28209473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markers of Follicular Helper T Cells Are Occasionally Expressed in T-Cell or Histiocyte-Rich Large B-Cell Lymphoma, Classic Hodgkin Lymphoma, and Atypical Paracortical HyperplasiaA Diagnostic Pitfall For T-Cell Lymphomas of T Follicular Helper Origin.
    Abukhiran I; Syrbu SI; Holman CJ
    Am J Clin Pathol; 2021 Aug; 156(3):409-426. PubMed ID: 33624021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma.
    Maura F; Agnelli L; Leongamornlert D; Bolli N; Chan WC; Dodero A; Carniti C; Heavican TB; Pellegrinelli A; Pruneri G; Butler A; Bhosle SG; Chiappella A; Di Rocco A; Zinzani PL; Zaja F; Piva R; Inghirami G; Wang W; Palomero T; Iqbal J; Neri A; Campbell PJ; Corradini P
    Am J Hematol; 2019 Jun; 94(6):628-634. PubMed ID: 30829413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma.
    de Leval L; Gisselbrecht C; Gaulard P
    Br J Haematol; 2010 Mar; 148(5):673-89. PubMed ID: 19961485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The gene expression profile of nodal peripheral T-cell lymphoma demonstrates a molecular link between angioimmunoblastic T-cell lymphoma (AITL) and follicular helper T (TFH) cells.
    de Leval L; Rickman DS; Thielen C; Reynies Ad; Huang YL; Delsol G; Lamant L; Leroy K; Brière J; Molina T; Berger F; Gisselbrecht C; Xerri L; Gaulard P
    Blood; 2007 Jun; 109(11):4952-63. PubMed ID: 17284527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project.
    Savage KJ; Harris NL; Vose JM; Ullrich F; Jaffe ES; Connors JM; Rimsza L; Pileri SA; Chhanabhai M; Gascoyne RD; Armitage JO; Weisenburger DD;
    Blood; 2008 Jun; 111(12):5496-504. PubMed ID: 18385450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The risk of central nervous system relapses in patients with peripheral T-cell lymphoma.
    Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Oki Y
    PLoS One; 2018; 13(3):e0191461. PubMed ID: 29538376
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of FoxP3 expression in peripheral T-cell lymphoma.
    Bonzheim I; Geissinger E; Tinguely M; Roth S; Grieb T; Reimer P; Wilhelm M; Rosenwald A; Müller-Hermelink HK; Rüdiger T
    Am J Clin Pathol; 2008 Oct; 130(4):613-9. PubMed ID: 18794055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic signatures in T-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?
    Iqbal J; Wilcox R; Naushad H; Rohr J; Heavican TB; Wang C; Bouska A; Fu K; Chan WC; Vose JM
    Blood Rev; 2016 Mar; 30(2):89-100. PubMed ID: 26319391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phosphorylated STAT3 as a potential diagnostic and predictive biomarker in ALK
    Xiang C; Wu W; Fan M; Wang Z; Feng X; Liu C; Liu J; Liu G; Xia L; Si H; Gu Y; Liu N; Luo D; Wang Y; Ma D; Hu S; Liu H
    Front Immunol; 2023; 14():1132834. PubMed ID: 37388733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification and diagnostic evaluation of nodal T- and NK-cell lymphomas.
    Feldman AL; Laurent C; Narbaitz M; Nakamura S; Chan WC; de Leval L; Gaulard P
    Virchows Arch; 2023 Jan; 482(1):265-279. PubMed ID: 36210383
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCL-2 family proteins in peripheral T-cell lymphomas: correlation with tumour apoptosis and proliferation.
    Rassidakis GZ; Jones D; Lai R; Ramalingam P; Sarris AH; McDonnell TJ; Medeiros LJ
    J Pathol; 2003 Jun; 200(2):240-8. PubMed ID: 12754745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.